Prescription opioid use among people with opioid dependence and concurrent benzodiazepine and gabapentinoid exposure
An analysis of overdose and all-cause mortality
Bibliographic Data
| ID | 14906116 |
|---|---|
| Authors | Chrianna Bharat (0000-0002-9778-0386, UNSW Sydney, corresponding author), Natasa Gisev (0000-0003-0452-8470, UNSW Sydney), Sebastiano Barbieri (0000-0002-5919-372X, UNSW Sydney), Timothy Dobbins (0000-0003-1841-9056, UNSW Sydney), Sarah Larney (0000-0002-5602-4963, Centre Hospitalier de l’Université de Montréal), Luke Buizen (UNSW Sydney), Louisa Degenhardt (0000-0002-8513-2218, UNSW Sydney) |
| Year | 2024 |
| Volume | 123 |
| Pages | 104287 |
| Publication date | 2024-01-01 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | International Journal of Drug Policy (JOURNAL) |
| Journal identifiers | ISSN: 0955-3959 • E-ISSN: 1873-4758 |
| Publisher | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.drugpo.2023.104287 |
| PMID | 38088003 |
| OpenAlex | W4389607118 |
| Language | EN |
| Citations received | 1 |
| References cited | 37 |
The increased mortality risk associated with benzodiazepines and gabapentinoids among PWOD appear to be reduced when engaged in OAT. A greater focus on encouraging OAT engagement, providing overdose prevention education, and access and coverage of overdose antidotes is necessary to minimise the unintended consequences of medicines use in this population
Analgesic · Anesthesia · Benzodiazepine · Drug overdose · Opioid · Poison control · Cardiac Arrest and Resuscitation · Medicine · Opioid Use Disorder Treatment · Pain Management and Opioid Use · Emergency Medicine · Internal Medicine
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence
Global patterns of opioid use and dependence
Association Between Opioid Prescribing Patterns and Opioid Overdose-Related Deaths
Use of promethazine, gabapentin and clonidine in combination with opioids or opioid agonist therapies among individuals attending a syringe service program
Safer opioid distribution in response to the Covid-19 pandemic
Factors associated with 60-day adherence to “safer supply” opioids prescribed under British Columbia's interim clinical guidance for health care providers to support people who use drugs during Covid-19 and the ongoing overdose emergency
The increase in benzodiazepine-laced drugs and related risks in Canada
| Citations per year | 1 |
|---|---|
| Citation span | 2026 - 2026 (1) |
| Highly cited | No |